Research & development > Life sciences

Drug hoped to treat CFS causes impaired immune function — study

28 March, 2018

Reports that a drug used to treat autoimmune diseases and cancer could also treat CFS have been refuted by a new Griffith University study.

Aussie zika vaccine begins US trial

28 March, 2018 by Andrew Spence

The first non-human primate trials of a dual vaccine developed in Australia for the zika and chikungunya viruses are about to begin in the United States.

Gold-coated nanowires restore visual response in blind mice

09 March, 2018

Scientists have restored visual responses in blind mice by transplanting artificial replacements for light-detecting cells into their eyes.

Fighting superbugs with their favourite food

06 March, 2018

Adelaide researchers have developed and patented a novel approach to fight superbugs by targeting the bugs' favourite food, iron.

Could Zika virus help battle brain cancer?

05 March, 2018

Zika virus could be used for treatment of glioblastoma, according to Brazilian researchers.

Regenerative medicine breakthrough

02 March, 2018

Australian and Dutch researchers have moved a step closer towards making human kidneys from stem cells.

3D scaffolds to grow muscle

26 February, 2018

Australian biomedical engineers have combined lab-made peptides with natural proteins and polymers to create a 3D 'hydrogel scaffold'.

CRISPR-based DNA detective

20 February, 2018

A CRISPR-based genetic detective could lead to fast, reliable medical tests.

Drug shown to reverse alcohol-related brain damage

12 February, 2018

Researchers have identified a drug that could reverse the damaging impacts of heavy alcohol consumption on the regeneration of brain cells.

Schrödinger's protein is both a conductor and an insulator

30 January, 2018 by Lauren Davis

US researchers have uncovered the first evidence of a protein that can conduct electricity like a metal — so long as the voltage is high enough.

Study raises concerns over animal trials

16 January, 2018

A recent investigation raises concerns over poor quality, lack of regulation and misrepresentation of animal studies for drug development.

Malaria mystery solved

11 January, 2018

An international collaboration, led by Melbourne researchers, has solved a longstanding malaria mystery.

Nucleic acids and immunity

15 December, 2017 by Mansi Gandhi

Dr Michael Gantier, Research Group Head, Nucleic Acids and Innate Immunity at the Hudson Institute in Melbourne, reflects on the latest developments in the field of infection and immunity and his lab's current focus and future plans.

Novel compound may restore immune response in melanoma patients

11 December, 2017

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland.

Australian-developed risk scoring system predicts childhood leukaemia relapse

04 December, 2017

Australian researchers have developed a new risk scoring system for children with leukaemia based on missing DNA fragments or ‘microdeletions’.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd